Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation　― Findings From the SAKURA AF Registry ―-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation　― Findings From the SAKURA AF Registry ―

Published:2018-09-25 Issue:10 Volume:82 Page:2500-2509
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Okumura Yasuo¹,Yokoyama Katsuaki²,Matsumoto Naoya²,Tachibana Eizo³,Kuronuma Keiichiro³,Oiwa Koji⁴,Matsumoto Michiaki⁴,Kojima Toshiaki⁵,Hanada Shoji⁶,Nomoto Kazumiki⁷,Arima Ken⁸,Takahashi Fumiyuki⁹,Kotani Tomobumi¹⁰,Ikeya Yukitoshi¹¹,Fukushima Seiji¹²,Itou Satoru¹³,Kondo Kunio¹⁴,Chiku Masaaki¹⁵,Ohno Yasumi¹⁶,Onikura Motoyuki¹⁷,Hirayama Atsushi¹,

Affiliation:

1. Division of Cardiology, Nihon University Itabashi Hospital

2. Department of Cardiology, Nihon University Hospital

3. Kawaguchi Municipal Medical Center

4. Yokohama Chuo Hospital

5. Sekishindo Hospital

6. Asakadai Central General Hospital

7. Tokyo Rinkai Hospital

8. Kasukabe Municipal Hospital

9. Yasuda Hospital

10. Makita General Hospital

11. Itabashi Medical Association Hospital

12. Ukima Central Hospital

13. Itou Cardiovascular Clinic

14. Kondo Clinic

15. Keiai Clinic

16. Ohno Medical Clinic

17. Onikura Clinic

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/82/10/82_CJ-18-0535/_pdf

Reference20 articles.

1. 1. JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013): Digest version. Circ J 2014; 78: 1997–2021.

2. 2. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139–1151.

3. 3. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883–891.

4. 4. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981–992.

5. 5. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013; 369: 2093–2104.

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The level of factor X coagulation and the risk of adverse reactions during treatment with rivaroxaban and apixaban in patients with non-valvular atrial fibrillation;Meditsinskiy sovet = Medical Council;2024-09-01

2. Association between preprocedural thromboembolic and bleeding events under oral anticoagulation therapy and mid-term outcomes after percutaneous left atrial appendage closure;Heart and Vessels;2024-06-05

3. External Validation of the HELT-E<sub>2</sub>S<sub>2</sub> Score in Japanese Patients With Nonvalvular Atrial Fibrillation　― A Pooled Analysis of the RAFFINE and SAKURA Registries ―;Circulation Journal;2023-11-24

4. Real‐world evidence that among atrial fibrillation patients warfarin is associated with reduced nonelective admissions compared with those on DOACs;Clinical Cardiology;2023-09-08

5. Phenotyping of atrial fibrillation with cluster analysis and external validation;Heart;2023-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3